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Body mass index (BMI) can be considered an application of a power law model to express body weight independently of height.
Based on the same power law principle, we previously introduced a body shape index (ABSI) to be independent of BMI and height.
Here, we develop a new hip index (HI) whose normalized value is independent of height, BMI, and ABSI. Similar to BMI, HI
demonstrates a U-shaped relationship to mortality in the Third National Health and Nutrition Examination Survey (NHANES
III) population. We further develop a new anthropometric risk index (ARI) by adding log hazard ratios from separate nonlinear
regressions of the four indicators, height, BMI, ABSI, and HI, against NHANES III mortality hazard. ARI far outperforms any of
the individual indicators as a linear mortality predictor in NHANES III. The superior performance of ARI also holds for predicting
mortality hazard in the independent Atherosclerosis Risk in Communities (ARIC) cohort. Thus, HI, along with BMI and ABSI, can
capture the risk profile associated with body size and shape. These can be combined in a risk indicator that utilizes complementary
information from height, weight, and waist and hip circumference. The combined ARI is promising for further research and clinical
applications.

1. Introduction
Body mass index (BMI) (weight [𝑊] relative to height [𝐻] as
𝑊/𝐻2 ) [1] has been robustly established to be independent
of height in numerous and diverse population studies and is
currently used in the definition of overweight and obesity.
Waist circumference (WC) has been used to indicate the
presence of abdominal obesity, with WC above threshold
forming one criterion for diagnosis of metabolic syndrome
[2, 3]. However, the high correlation (0.8–0.9) found between
BMI and WC or WC-derived measures such as WC/H ratio
[4–6] and body roundness index [7, 8] limit the utility of these
measures beyond BMI.
BMI traces back to the pioneering 1800s statistician
Quetelet, who postulated a power-law relationship between
height and weight [9]. BMI can be considered a special case
of the concept of power-law scaling of body dimensions
(allometry), developed in biology during the early 1900s [10].
Building on these ideas, we previously applied regression

based on power-law scaling to derive an index (a body
shape index [ABSI]) that expresses waist circumference (WC)
relative to height and weight and was therefore statistically
independent of BMI [11]. Odds ratios for mortality in several
longitudinal studies showed a U-shaped distribution across
BMI and a positive linear association with ABSI [12–14].
Hip circumference (HC) and derived measures such as
waist to hip ratio (WC/HC, WHR) have also been studied
extensively as risk factors [15–17]. However, HC and WHR are
typically highly correlated to BMI or WC, and several studies
have failed to show added value of HC-based indicators
compared to those only based on 𝐻, 𝑊, and WC [18–20].
In general, comparisons of various indices based on 𝐻,
𝑊, WC, and HC have shown that different individual indices
may perform approximately equally well as predictors of
mortality and conditions such as heart disease [14, 20–25].
While the joint use of multiple indices could improve risk
prediction, high correlations between different measures are
one reason that there is as yet no clear methodology to
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obtain combinations of indicators that outperform the ones
currently used [26–28].
Here, we propose a new approach to transform 𝐻, 𝑊,
WC, and HC to an anthropometric risk index (ARI). The
first step in this approach was to reexpress 𝐻, 𝑊, WC, and
HC data as derived indicators that are almost uncorrelated
with each other. The proposed set of independent indicators
includes 𝐻, BMI, ABSI, and a newly developed hip index
(HI).
We use nonlinear (penalized spline) regression with data
from the Third National Health and Nutrition Examination
Survey (NHANES III), a United States (USA) general population sample with some 20 years of follow-up for mortality, to
estimate a functional relationship between each indicator and
mortality hazard within the Cox proportional hazard framework. ARI is formed by summing the estimated logarithms
of hazard ratios due to each of the independent indicators
and constitutes a linear predictor for logarithm of mortality
hazard. We demonstrate that ARI is transferable beyond the
cohort in which it is developed by applying it to mortality
outcomes of a different USA cohort study, Atherosclerosis
Risk in Communities (ARIC). The ARI approach developed
here could be applied to produce risk indices for various
conditions that make maximum use of readily obtained body
measurements for research and clinical decision-making.

2. Methods
2.1. Ethics Statement. We analyzed data from the NHANES
III and ARIC studies. The NHANES III and ARIC protocols
were approved by the NHANES Institutional Review Board
and the University of North Carolina at Chapel Hill Office
of Human Research Ethics, respectively, and all participants
gave written informed consent [29, 30]. The present analysis
of the already-anonymized public-use data from these studies
was approved as exempt from review by the University
Integrated Institutional Review Board of the City University
of New York.
2.2. Data. NHANES III sampled the civilian noninstitutionalized USA population using a cluster approach, with some
groups of public health interest (children, the elderly, and
black and Mexican-American people) deliberately oversampled [31]. The data collected were used to study the prevalence
of health behaviors and risk factors, including anthropometric parameters [27, 32–35]. Subjects were interviewed and
examined during 1988–1994. Linked mortality outcomes for
adult subjects were available from the National Center for
Health Statistics with follow-up through 2011 (17–23 years
of follow-up). These mortality outcomes were derived from
probability matching with the National Death Index, with
those not matched to a death record assumed to have stayed
alive through the end of the period. For NHANES III, height
was measured with a stadiometer, weight with a digital scale,
WC with a steel tape about the high point of the iliac crest at
minimal respiration, and HC at the maximum extension of
the buttocks [36]. We analyzed NHANES III public-use data
for all nonpregnant adults (age 18 and over) with 𝐻, 𝑊, WC,
and HC measurements and mortality follow-up.
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The ARIC cohort component sampled 4,000 adults (age
45–64) in each of the 4 USA communities during 1987–1989
to study correlates of heart disease risk [29, 37–39]. ARIC
participants were visited several times in subsequent decades
for follow-up examinations [40]. We obtained ARIC publicuse repository data v2015a from the National Institutes of
Health Biologic Specimen and Data Repository Information
Coordinating Center (BIOLINCC), containing follow-up for
mortality outcomes through 2010 (21–23 years of follow-up).
We analyzed the ARIC data for all adults with initial 𝐻, 𝑊,
WC, and HC measurements and mortality follow-up.
Except where otherwise specified, we used the provided
sample weights [31] in all analyses of the NHANES III data so
that our results would be better estimates for anthropometric
normals and correlations with mortality hazard in the general
USA population. The ARIC analyses weight all participants
equally.
2.3. Analysis. H, BMI, and ABSI have been found to be
mutually almost uncorrelated (correlation coefficient magnitudes |𝑟| < 0.1) in several cohorts [13]. To obtain a fourth
index uncorrelated with these three, we followed a procedure
similar to that used to construct ABSI [11], seeking a powerlaw relationship between HC (cm) and 𝐻 (cm) and 𝑊 (kg),
adjusted for sex, in NHANES III nonpregnant adults by
linear regression of the natural logarithms. The least-square
regression line was
log (HC) = 2.658 − 0.310 log (𝐻) + 0.482 log (𝑊)
+ 0.083𝑓,

(1)

where the indicator 𝑓 is set at 1 for females and 0 for males
(𝑅2 = 0.887). Based on this relationship, we defined a normalized HC, or HI, as
HI ≡ HC (

𝐻 0.310 𝑊 −0.482
(
)
)
,
⟨𝐻⟩
⟨𝑊⟩

(2)

where ⟨𝐻⟩ = 166 cm and ⟨𝑊⟩ = 73 kg were average values. HI
can be understood as the HC of a given person normalized to
a standard height and weight (ABSI could also be expressed
in an analogous normalized form and denote WC normalized
to a standard height and weight).
Cox proportional hazard modeling [41] was used to assess
the impact of the anthropometric indices 𝐻, BMI, ABSI,
and HI on death rate (mortality hazard) over the follow-up
periods [13]. In addition to body measurements, age (used as
the timescale in the Cox model), sex (male/female), and race
(black/nonblack) were also retained for modeling mortality
hazard. Body measurements were normalized to age- and
sex-specific 𝑧 scores [13] based on NHANES III means and
standard deviations before being entered into the model.
These 𝑧 scores for 𝐻, BMI, ABSI, and HI were found, in
both NHANES III and ARIC, to indeed be mutually almost
uncorrelated, whereas WC and HC had high correlations
(about 0.9) and WHR had moderate correlation (about 0.4–
0.5) with BMI (Tables 1 and 2).
Both linear and nonlinear associations with mortality
hazard were modeled for each index for both NHANES III
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Table 1: Correlations of body measures in NHANES III.

Height
Weight
BMI
WC
HC
ABSI
WHR
HI

Height
1
0.360
−0.011
0.152
0.247
0.059
−0.056
0.016

Weight
0.486
1
0.919
0.904
0.933
0.028
0.415
0.034

BMI
−0.010
0.863
1
0.905
0.903
0.007
0.468
0.031

WC
0.213
0.872
0.876
1
0.867
0.385
0.699
0.028

HC
0.079
0.821
0.905
0.791
1
0.030
0.260
0.356

ABSI
0.074
0.115
0.083
0.506
0.040
1
0.717
0.030

WHR
0.252
0.413
0.413
0.736
0.173
0.777
1
−0.459

HI
−0.528
−0.251
0.021
−0.154
0.319
−0.132
−0.599
1

Correlation coefficients for body measures among NHANES III nonpregnant adults. The upper-right triangle of the table shows correlations of the raw values,
while the lower-left triangle shows correlations of the 𝑧 scores relative to age- and sex-specific means.

Table 2: Correlations of body measures in ARIC.

Height
Weight
BMI
WC
HC
ABSI
WHR
HI

Height
1
0.322
−0.067
0.089
0.191
0.059
−0.057
0.010

Weight
0.471
1
0.747
0.706
0.790
−0.009
0.287
0.009

BMI
−0.053
0.851
1
0.894
0.893
0.041
0.493
−0.049

WC
0.165
0.862
0.882
1
0.855
0.450
0.733
−0.009

HC
0.009
0.793
0.900
0.821
1
0.082
0.284
0.317

ABSI
0.031
0.048
0.038
0.455
0.070
1
0.724
0.088

WHR
0.279
0.525
0.429
0.724
0.205
0.691
1
−0.442

HI
−0.560
−0.308
−0.015
−0.113
0.307
0.038
−0.571
1

The same as Table 1, but for ARIC.

and ARIC and compared to a baseline model with only sex
and race as predictors. In the linear proportional hazard
models, death rate increases or decreases by a constant factor
per standard deviation change in the index (unit change
in 𝑧 score). Nonlinear associations were estimated using a
penalized spline basis, with the corrected Akaike information
criterion (AIC) used to choose the amount of smoothing [42–
44].
The main measure of relative model performance was
AIC difference score, Δ 𝑖 . For the best-performing model
(with lowest AIC), Δ 𝑖 = 0, while other models have positive
Δ 𝑖 [45]. Δ 𝑖 > 6 indicated models that perform significantly
worse than the best-performing model (at the 95% confidence level) as mortality predictors for the sampled population [13]. We also calculated coefficients 𝑅2 , denoting
the proportion of variation in mortality explained by the
predictors of each model, so that higher 𝑅2 suggests a model
with more explanatory power [46]. Another measure of
model performance checked was concordance (𝐶), defined
as the fraction of pairs of individuals in the sample for
which the one modeled to be at greater risk actually died
sooner [41]. Concordance ranges from 0 to 1, with 0.5 being
the expected value for models with no skill and higher
values denoting models that are more skillful at explaining
variation in survival. Regressions were carried out in the R
environment [47], using the survival [48] package for the
model fitting and calculation of AIC and 𝐶 scores and the
survMisc [49] package for calculating model 𝑅2 .
Nonlinear modeling for mortality hazard associated with
each anthropometric index yielded functions for the natural

logarithm of the estimated hazard for different values of the 𝑧
score of that particular index. ARI was taken to be the sum
of these function values for each individual’s combination
of anthropometric index 𝑧 scores, denoting the natural
logarithm of the combined estimated hazard from the four
independent indices H, BMI, ABSI, and HI. Assuming that
these four hazards are independent, ARI then is the natural
logarithm of the mortality hazard based on all four measurements H, W, WC, and HC, with positive values denoting
above-average combined risk and negative values denoting
lower risk. ARI calculated based only on NHANES normals
and outcome data was applied to the ARIC population to test
whether it is transferable beyond the original cohort used to
obtain the population normals and hazard estimates.

3. Results
While the ARIC cohort was on average older than NHANES
III or the national adult population, the groups had fairly
similar body measurements on initial examination, with most
individuals in the overweight or obese BMI ranges (Table 3).
Associations with mortality hazard of H, BMI, ABSI, and
HI 𝑧 scores were also broadly similar for the NHANES III
and ARIC cohorts, though there were significant differences
in detail. Out of H, BMI, ABSI, and HI, the best linear
predictor for log mortality was ABSI for both datasets. BMI
was a weaker but also statistically significant linear predictor
for both cohorts, while HI was only statistically significant
as a linear predictor in ARIC, and H was only marginally
significant for both cohorts (Tables 4 and 5).

4

Journal of Obesity
Table 3: NHANES III and ARIC means.
NHANES III

NHANES III (weighted)

ARIC

Number
Deaths
% female

16034
4897
52

51

14917
4829
51

% black
Age (y)

28
43 (30–63)

11
41 (30–57)

24
54 (49–59)

166 (159–174)
73 (63–85)
26 (23–30)

168 (161–176)
73 (62–85)
25 (22–29)

168 (161–176)
78 (67–89)
27 (24–30)

92 (82–102)
99 (93–106)

90 (80–101)
99 (93–106)

96 (88–105)
103 (98–109)

0.92 (0.85–0.98)
0.0803 (0.0764–0.0841)
100 (96–105)

0.91 (0.84–0.97)
0.0798 (0.0761–0.0834)
100 (96–105)

0.94 (0.88–0.98)
0.0823 (0.0792–0.0852)
102 (98–106)

Height (cm)
Weight (kg)
BMI (kg m−2 )
WC (cm)
HC (cm)
WHR
ABSI (m11/6 kg−2/3 )
HI (cm)

Comparison of demography and body measurements in the NHANES III and ARIC cohorts. For age and for body measurements, medians and interquartile
ranges are given. For NHANES III, frequencies and quantiles were also calculated with the sample weights given to better represent the national population.

Table 4: Mortality hazard association with body measures in NHANES III.
Predictor
ARI (linear)
BMI (nonlinear)
ABSI (nonlinear)
ABSI (linear)
HI (nonlinear)
BMI (linear)
𝐻 (nonlinear)

Hazard ratio per SD increase

Δ𝑖

𝑅2

𝐶

1.46 (1.41–1.52)

0
187.2

0.065
0.046

0.615
0.591

247.3
256.4

0.036
0.034

0.585
0.584

314.6
326.4
327.5

0.028
0.025
0.027

0.567
0.570
0.569

1.16 (1.12–1.20)
1.07 (1.04–1.10)

𝐻 (linear)
None

0.96 (0.93–0.99)

336.4
342.8

0.024
0.023

0.562
0.555

HI (linear)

0.99 (0.96–1.02)

343.9

0.023

0.558

Results of Cox proportional hazard modeling for mortality risk in NHANES III with 𝐻, BMI, ABSI, HI, or ARI 𝑧 scores taken as linear or nonlinear predictors.
All models also included as predictors sex and race. Ranges in parentheses are 95% confidence intervals for the hazard ratio. Models are arranged in decreasing
order of skill (increasing Δ 𝑖 ).
SD: standard deviation; Δ 𝑖 : Akaike information criterion score difference relative to the best-performing model shown (see Methods for details); 𝑅2 : measure
of explained variation; 𝐶: concordance.

In nonlinear (penalized spline) regression models, BMI
and HI showed asymmetric U-shaped associations with
mortality in both cohorts, while associations with H and
ABSI were basically monotonic. The optimum BMI (lowest
mortality hazard) was around half a standard deviation under
the population median (in the World Health Organization
“normal” category) for both NHANES III and ARIC. However, the optimum HI was higher for ARIC than for NHANES
III (Figure 1). As measured by Δ 𝑖 as well as 𝑅2 and 𝐶, ABSI and
BMI had the strongest nonlinear associations with mortality
in both cohorts (Tables 4 and 5).
In NHANES III, ARI was a significantly better linear
predictor than any of the (linear or nonlinear) models based
on individual indicators (H, BMI, ABSI, and HI) (Table 4).
ARI derived from NHANES III data predicted mortality
hazard for the ARIC cohort better than any model based
on one of the individual indicators (Table 5), despite the

difference in detail in the anthropometry associations with
mortality hazard of the two cohorts.

4. Discussion
The difference in optimum BMI found between the NHANES
III and ARIC cohorts, on the one hand, and the more
recently enrolled NHANES 1999–2004 cohort, on the other
hand [11], is consistent with variations in optimum BMI
seen between different population studies [25, 50–58]. The
U-shaped association of mortality hazard with relative hip
circumference (HI 𝑧 score) has not been reported before, to
our knowledge. The strong performance of ABSI, compared
to other anthropometric indices, as a near-linear predictor
of log mortality hazard is consistent with analyses of other
cohorts [12–14, 25]. Our results suggest that these associations
of mortality risk with different measures of body size and
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Table 5: Mortality hazard association with body measures in ARIC.

Predictor

Hazard ratio per SD increase

Δ𝑖

𝑅2

𝐶

1.43 (1.38–1.49)
1.26 (1.22–1.30)

0
86.0

0.103
0.093

0.622
0.616

86.4
121.9
221.5

0.093
0.090
0.078

0.616
0.613
0.606

ARI (linear)
ABSI (linear)
ABSI (nonlinear)
BMI (nonlinear)
HI (nonlinear)
BMI (linear)
HI (linear)

1.11 (1.08–1.15)
0.92 (0.89–0.95)

277.3
294.4

0.070
0.067

0.601
0.602

𝐻 (linear)
None
𝐻 (nonlinear)

0.96 (0.93–0.99)

312.0
317.4
318.8

0.065
0.064
0.066

0.596
0.593
0.597

The same as Table 4, but for the ARIC cohort.

shape can be combined in a single robust linear predictor,
ARI.
Previously, anthropometric indices have not included all
four of the measurements H, W, WC, and HC, although each
of these measurements has been separately found to be a
significant determinant of health risk in various studies. The
ARI approach can combine the risk associated with these
four measurements and potentially also others such as thigh
circumference [59], X-ray body composition measures [60,
61], or body dimensions from laser scanning [62, 63].
Although our ARI is a substantially better predictor of
mortality risk than any of the individual anthropometric
indices tested, its absolute predictive value is modest for
the cohorts and follow-up periods tested: the measure of
explained variation 𝑅2 increases by about 0.04, while concordance increases by about 0.03–0.06, relative to a background
predictive model with no anthropometric data (Tables 4 and
5). In fact, self-reported health and smoking history have
been found to be the best single predictors of 5-year mortality
[64], probably outperforming any anthropometrics. The ARI
approach could provide a way to incorporate such indicators
as well as laboratory measurements and anthropometric
indices into reliable combined risk estimates, expressing these
in terms of statistically independent components whose attributable risks can then be summed.
Commonly, WC but not HC is measured. In such cases,
ARI could be modified to sum only risk due to the indicators
H, BMI, and ABSI. Note that, in both the NHANES III and
ARIC cohorts, BMI and ABSI are better nonlinear indicators
of mortality hazard compared to HI and H (Tables 4 and 5),
suggesting that this truncated ARI would retain most of the
predictive power of the fuller version used here.
One potential drawback of ARI as calculated from
cohorts such as NHANES III is that it is not a simple function of H, W, WC, and HC, so that determining its value
for a particular individual from these measurements would
require either lookup tables or a computer program. This
complexity could be overcome as an obstacle to clinical use
via online calculators (analogous to the calculator developed
for estimating combined risk from BMI and ABSI [11, 65],

currently available online at https://nirkrakauer.net/sw/absicalculator.html) or apps for desktop and mobile device use.
We have developed a prototype online calculator for computing NHANES III ARI from H, W, WC, and HC values, available at https://nirkrakauer.net/sw/ari-calculator.html. The
NHANES III population means and standard deviations
and risk curves needed to carry out this ARI computation
are also available in spreadsheet form as a supplement to
this article (in Supplementary Material available online at
http://dx.doi.org/10.1155/2016/8094275).
The work presented here has several limitations that could
be addressed in future studies. The quality of the mortality
follow-up information from NHANES III and ARIC has
not been, to our knowledge, rigorously verified, raising the
possibility of some bias in the estimated risks, although the
consistency across the two cohorts of the associations of
mortality with initially measured anthropometric variables
is reassuring. The data we use here is only from USA. It is
likely that the NHANES III derived ARI should be modified
for application to non-USA populations [66]; this could
be done by calibration to other large cohort studies with
mortality follow-up. To assess the usefulness of combined
indices for specific clinically used classification schemes and
decisions, performance measures such as net reclassification
improvement (NRI) and integrated discrimination improvement (IDI) that are based on particular concepts of value to
clinical decision-making [67, 68] could be calculated.
The approach used to compute ARI here for hazard of
all-cause mortality could also be extended to derive risk
indices customized for specific causes of death and morbidity
outcomes such as heart disease, stroke, or diabetes, which
could facilitate individualized cost-benefit consideration in
deciding what medical interventions to undertake [69–71].
One recent study found that anthropometric indices (ABSI
and WC/H ratio) were correlated with Framingham and
SCORE 10-year cardiovascular risk estimates in a nationally
representative Turkish sample [72], while another study
found anthropometry-based indices (specifically ABSI) to
predict cardiovascular disease in middle-aged and elderly
Dutch adults as well as a risk model that included laboratory
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Figure 1: Estimated mortality hazard ratios in NHANES III and ARIC as nonlinear (penalized spline) functions of normalized (a) height, (b)
BMI, (c) ABSI, and (d) HI. Dashed lines indicate 95% confidence intervals. Percentiles and 𝑧 scores are based on the NHANES III cohort.

measurements [73], highlighting the potential for utilization
of a combination of several readily obtained body measurements for cardiometabolic risk assessment.

5. Conclusions
We derived and tested a combined anthropometric risk
index that takes into account multiple body measurements to
arrive at a risk score that outperforms the individual indices
previously used. The allometry-inspired methodology used

to arrive at the components of this index can potentially
be applied to define mutually independent indices from a
broad range of biometric and other variables and has the
potential to help elucidate the findings from association and
observational studies.
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